Shares of Catalyst Pharmaceuticals fell 2.82% to $3.45 at 13:38 EST on Friday, following last session’s upward trend. NASDAQ Composite is rising 0.22% to $13,095.65, following last session’s upward trend, This seems, up to now, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.55, 53.04% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was 2.01%, 0.77%, and 0.17%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.20%, 4.79%, and 5.04%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.45 at 13:38 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is below its 50-day moving average of $3.53 and below its 200-day moving average of $3.68.

LEAVE A REPLY

Please enter your comment!
Please enter your name here